Archived Newsletters
-
11.05.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing
11/5/2025
11/05/25 Outsourced Pharma Newsletter
-
11.04.25 -- Transforming Oral Therapeutics With Advanced TPD Technologies
11/4/2025
11/04/25 Outsourced Pharma Newsletter
-
11.04.25 -- Will It Not Die? The BIOSECURE Act Back With Iterations
11/4/2025
11/04/25 Outsourced Pharma Newsletter
-
11.03.25 -- Simplify The Journey Of Advancing Your Therapies To Patients
11/3/2025
11/03/25 Outsourced Pharma Newsletter
-
11.03.25 -- STREAM Edition: Second Sourcing Is Natural ... Your Current CDMO Should Understand
11/3/2025
11/03/25 Outsourced Pharma Newsletter
-
11.03.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing
11/3/2025
11/03/25 Outsourced Pharma Newsletter
-
10.31.25 -- Consistent OOF Delivery Performance That Defines Manufacturing Reliability
10/31/2025
10/31/25 Outsourced Pharma Newsletter
-
10.31.25 -- Italy A Quiet Outsourcing Standout For Drug Manufacturing?
10/31/2025
10/31/25 Outsourced Pharma Newsletter
-
10.30.25 -- Advancing Cell & Gene Therapies: Inside Leading CDMO Innovations
10/30/2025
10/30/25 Outsourced Pharma Newsletter
-
10.30.25 -- Looking to outsource pDNA or mRNA process development?
10/30/2025
10/30/25 Outsourced Pharma Newsletter